{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:26:42Z","timestamp":1793780802664,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Parkinson\u2019s disease (PD) exerts a considerable burden on the elderly. Studies on long-term costs for Parkinson\u2019s disease patients in Taiwan are not available.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study aims to examine the medical resource utilization and medical costs including drug costs for PD patients in Taiwan over up to 15\u00a0years of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Incident PD patients and matched non-PD subjects were identified between 2003 and 2016 from the National Health Insurance (NHI) research database. Differences in annual healthcare utilization and costs between PD and non-PD subjects from 2003 to 2018 were predicted by generalized linear models. We performed analyses stratified by PD severity and also by age, gender, and duration of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 50,290 PD cases and 201,153 non-PD subjects. From the payer\u2019s perspective, the average total medical costs (drug costs) associated with PD and non-PD subjects were NT$631,080 (NT$222,810) and NT$480,880 (NT$140,120), respectively. Total medical and drug costs of PD after diagnosis remained high, from NT$138,487 per patient in the first year following diagnosis up to NT$154,676 per patient at year 15. The largest components of costs were for outpatient care (55% of total medical costs), and total drugs cost (35% of total medical costs). Patients with severe PD incurred higher total medical costs compared to those with moderate or mild PD, with outpatient and inpatient costs as well as drug costs rising with disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study of its kind in Taiwan that comprehensively analyzes long-term healthcare utilization and costs among PD patients. PD imposes a significant economic burden in Taiwan, with medical (drug) costs being 1.31 (1.59) times that of non-PD individuals and costs increasing substantially with PD severity. Our findings can aid health policymakers in understanding the healthcare needs and medical costs of PD patients, supporting effective policy formulation.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-024-03988-3","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:33:11Z","timestamp":1735885991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Healthcare utilization and costs for patients with Parkinson\u2019s disease in Taiwan"],"prefix":"10.1186","volume":"25","author":[{"given":"Kuan-Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jung Elizabeth","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"3988_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nj7526-299a","volume":"515","author":"K Gammon","year":"2014","unstructured":"Gammon K. Neurodegenerative disease: brain windfall. Nature. 2014;515:299\u2013300.","journal-title":"Nature"},{"key":"3988_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, et al. Current and projected future economic burden of Parkinson\u2019s disease in the US. NPJ Parkinsons Dis. 2020;6:15.","journal-title":"NPJ Parkinsons Dis"},{"key":"3988_CR3","first-page":"8756359","volume":"2016","author":"CC Liu","year":"2016","unstructured":"Liu CC, Li CY, Lee PC, Sun Y. Variations in incidence and prevalence of Parkinson\u2019s disease in Taiwan: a population-based nationwide study. Park Dis. 2016;2016:8756359.","journal-title":"Park Dis"},{"key":"3988_CR4","first-page":"1950","volume":"2016","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Wu H, Jones J. Healthcare data analytics for Parkinson\u2019s disease patients: a study of hospital cost and utilization in the United States. AMIA Ann Symp Proc. 2017;2016:1950\u20138.","journal-title":"AMIA Ann Symp Proc"},{"key":"3988_CR5","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.18632\/oncotarget.23298","volume":"9","author":"F Yang","year":"2017","unstructured":"Yang F, et al. Increased risk of Parkinson\u2019s disease following tension-type headache: a nationwide population-based cohort study. Oncotarget. 2017;9:2148\u201357.","journal-title":"Oncotarget"},{"key":"3988_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1468-1331.2010.03210.x","volume":"18","author":"YJ Zhao","year":"2011","unstructured":"Zhao YJ, et al. Economic burden of Parkinson\u2019s disease in Singapore. Eur J Neurol. 2011;18:519\u201326.","journal-title":"Eur J Neurol"},{"key":"3988_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson\u2019s disease in the United States. Move Disord. 2013;28:311\u20138.","journal-title":"Move Disord"},{"key":"3988_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/mdc3.12765","volume":"6","author":"KT Stroupe","year":"2019","unstructured":"Stroupe KT, et al. Healthcare utilization and costs for patients with Parkinson\u2019s disease after deep brain stimulation. Move Disord Clin Pract. 2019;6:369\u201378.","journal-title":"Move Disord Clin Pract"},{"key":"3988_CR9","first-page":"5932675","volume":"2017","author":"S Bohingamu Mudiyanselage","year":"2017","unstructured":"Bohingamu Mudiyanselage S, et al. Cost of living with Parkinson\u2019s disease over 12 months in Australia: a prospective cohort study. Parkinsons Dis. 2017;2017:5932675.","journal-title":"Parkinsons Dis"},{"key":"3988_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/mds.27302","volume":"33","author":"S Weir","year":"2018","unstructured":"Weir S, et al. Short- and long-term cost and utilization of health care resources in Parkinson\u2019s disease in the UK. Move Disord. 2018;33:974\u201381.","journal-title":"Move Disord"},{"key":"3988_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12883-024-03949-w","volume":"24","author":"R Akhmedullin","year":"2024","unstructured":"Akhmedullin R, Supiyev A, Kaiyrzhanov R, et al. Burden of Parkinson\u2019s disease in Central Asia from 1990 to 2021: findings from the global burden of disease study. BMC Neurol. 2024;24:444. https:\/\/doi.org\/10.1186\/s12883-024-03949-w.","journal-title":"BMC Neurol"},{"key":"3988_CR12","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.prdoa.2020.100046","volume":"3","author":"N Dahodwala","year":"2020","unstructured":"Dahodwala N, et al. Use of a medication-based algorithm to identify advanced Parkinson\u2019s disease in administrative claims data: associations with claims-based indicators of disease severity. Clin Parkinson Relat Disord. 2020;3:100046.","journal-title":"Clin Parkinson Relat Disord"},{"key":"3988_CR13","unstructured":"National Health Insurance Administration Ministry of Health and Welfare. 2016-2017 annual report, national health insurance. 2016. https:\/\/media.nhi.gov.tw\/md\/dl-51863-19fec8b37a854d83a062489efea28aea-3.pdf."},{"key":"3988_CR14","doi-asserted-by":"publisher","first-page":"e025274","DOI":"10.1136\/bmjopen-2018-025274","volume":"9","author":"CC Liu","year":"2019","unstructured":"Liu CC, Sun Y, Lee PC, Li CY, Hu SC. Risk of dementia after Parkinson\u2019s disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims. BMJ Open. 2019;9:e025274.","journal-title":"BMJ Open"},{"key":"3988_CR15","first-page":"24","volume":"Special Issue 2","author":"LJE Ku","year":"2018","unstructured":"Ku LJE, Li CC, Liao YH. The establishment and application of National Health Insurance (NHI) Global Budget (GB) point value database. J Health Sci. 2018;Special Issue 2018:24\u201332.","journal-title":"J Health Sci"},{"key":"3988_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"3988_CR17","first-page":"1","volume":"4","author":"CY Liu","year":"2006","unstructured":"Liu CY, et al. Incorporating development stratification of taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;4:1\u201322.","journal-title":"J Health Manag"},{"key":"3988_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/mds.20999","volume":"21","author":"G Wang","year":"2006","unstructured":"Wang G, et al. Economic burden of Parkinson\u2019s disease in a developing country: a retrospective cost analysis in Shanghai, China. Move Disord. 2006;21:1439\u201343.","journal-title":"Move Disord"},{"key":"3988_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.21035","volume":"21","author":"M Ragothaman","year":"2006","unstructured":"Ragothaman M, Govindappa ST, Rattihalli R, Subbakrishna DK, Muthane UB. Direct costs of managing Parkinson\u2019s disease in India: concerns in a developing country. Move Disord. 2006;21:1755\u20138.","journal-title":"Move Disord"},{"key":"3988_CR20","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.parkreldis.2007.06.003","volume":"13","author":"LJ Findley","year":"2007","unstructured":"Findley LJ. The economic impact of Parkinson\u2019s disease. Parkinson Relat Disord. 2007;13:S8\u201312.","journal-title":"Parkinson Relat Disord"},{"key":"3988_CR21","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/mds.22705","volume":"24","author":"M Barichella","year":"2009","unstructured":"Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson\u2019s disease. Move Disord. 2009;24:1881\u201392.","journal-title":"Move Disord"},{"key":"3988_CR22","doi-asserted-by":"publisher","first-page":"e0148779","DOI":"10.1371\/journal.pone.0148779","volume":"11","author":"LJE Ku","year":"2016","unstructured":"Ku LJE, Pai MC, Shih PY. Economic impact of Dementia by disease severity: exploring the relationship between stage of Dementia and cost of care in Taiwan. PLoS One. 2016;11:e0148779.","journal-title":"PLoS One"},{"key":"3988_CR23","first-page":"S183","volume":"18","author":"DL Murman","year":"2012","unstructured":"Murman DL. The impact of age on cognition. Am J Manag Care. 2012;18:S183\u20138.","journal-title":"Am J Manag Care"},{"key":"3988_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1353-8020(02)00097-4","volume":"9","author":"T Ker\u00e4nen","year":"2003","unstructured":"Ker\u00e4nen T, et al. Economic burden and quality of life impairment increase with severity of PD. Parkinson Relat Disord. 2003;9:163\u20138.","journal-title":"Parkinson Relat Disord"},{"key":"3988_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2165\/11310160-000000000-00000","volume":"27","author":"Y Winter","year":"2009","unstructured":"Winter Y, et al. Costs of illness in a Russian cohort of patients with Parkinson\u2019s disease. Pharmacoeconomics. 2009;27:571\u201384.","journal-title":"Pharmacoeconomics"},{"key":"3988_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Yang YHK, Lai ECC. Taiwan\u2019s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03988-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03988-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03988-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:08:49Z","timestamp":1735888129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03988-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3988"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03988-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. The study was approved by the Human Research Ethics Committee at National Cheng Kung University (NCKU HREC), for ensuring the rights and welfare of research participants are adequately protected (Approval No. NCKU HREC-E-111-491-2). Due to the use of deidentified information from nationwide databases. Informed consent is waived by the Institutional Review Board (IRB) of the Taiwan Adventist Hospital (110-E-02) and the National Cheng Kung University Human Research Ethics Committee (NCKU HREC-E-111-49-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}